There are numerous challenges involved when moving investigational therapeutics from the bench to the clinic. In this presentation, Asymchem’s Director of Process Chemistry,  Joshua Bolger will share our approach to the successful manufacture of oligonucleotide drug substances.

    Fill out the form below to view this presentation